The deadly legacy of the Fukushima disaster
Child cancer rates are 20 to 50 times above average near melted-down plant
TOKYO— A new study says children living near the Fukushima nuclear meltdowns have been diagnosed with thyroid cancer at a rate 20 to 50 times that of children elsewhere, a difference the authors contend undermines the government’s position that more cases have been discovered in the area only because of stringent monitoring.
Most of the 370,000 children in Fukushima prefecture have been given ultrasound checkups since the March 2011 meltdowns at the tsunami-ravaged Fukushima Dai-ichi nuclear plant. The most recent statistics, released in August, show that thyroid cancer is suspected or confirmed in 137 of those children, a number that rose by 25 from a year earlier. Elsewhere, the disease occurs in only about one or two of every million children per year by some estimates.
“This is more than expected and emerging faster than expected,” lead author Toshihide Tsuda told The Associated Press during a visit to Tokyo. “This is 20 times to 50 times what would be normally expected.”
The study was released online this week and is being published in the November issue of Epidemiology, produced by the Herndon, Va.-based International Society for Environmental Epidemiology. The data comes from tests overseen by Fukushima Medical University.
Making sense of the relationship between radiation and cancer is precarious: It’s scientifically impossible to link an individual cancer case to radiation. Looking harder with routine checkups, like the one in Fukushima, leads to quicker discovery of tumours, inflating the tallies in a so-called “screening effect.”
Right after the disaster, the lead doctor brought in to Fukushima, Shunichi Yamashita, repeatedly ruled out the possibility of radiation- induced illnesses. The thyroid checks were ordered just to play it safe, according to the government.
But Tsuda, a professor at Okayama University, said the latest results from the ultrasound checkups, which continue to be conducted, raise doubts about the government’s view.
Thyroid cancer among children is one sickness the medical world has definitively linked to radiation after the 1986 Chornobyl catastrophe. If treated, it is rarely fatal and early detection is a plus, but patients are on medication for the rest of their lives.
Scientists are divided on Tsuda’s conclusions.
In the same Epidemiology issue, Scott Davis, professor at the Department of Epidemiology in the Seattlebased School of Public Health, said the key limitation of Tsuda’s study is the lack of individual-level data to estimate actual radiation doses.
Davis agreed with the findings of the World Health Organization and UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), both of which have carried out reviews on Fukushima and predicted cancer rates will remain stable, with no rises being discernable as radiation-caused.
David J. Brenner, professor of radiation biophysics at Columbia University Medical Center, took a different view. While he agreed individual estimates on radiation doses are needed, he said in a telephone interview that the higher thyroid cancer rate in Fukushima is “not due to screening. It’s real.”
Conclusions about any connection between Fukushima radiation and cancer will help determine compensation and other policies.